Predictors of outcomes with CD3 x CD20 bispecific antibodies after CAR-T failure in B-cell lymphoma
3:53
Bispecific antibodies in cancer immunotherapy
2:59
Retreatment with R-CHOP-like therapy in patients with late relapse of DLBCL
23:13
Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute
8:11
MPN Research Spotlight: Highlights from ASH 2024
16:21
Dramatic neurological improvement after perispinal etanercept treatment by Edward Tobinick, M.D.
2:47
What are bispecific antibodies?
3:10
Increased risk of leukemic transformation and worse survival in patients with TP53-mutated MPNs
3:00